EUVIMEDEUVIMED entdecken
Crossref

Silencing of lncRNA PRR34 ‐ AS1 Alleviates Alzheimer's Disease by Targeting miR ‐29c‐3p to Regulate Microglia Inflammation

Xing Cheng, Hong-Fang Chen, Jian-Wei Wang, Xin-Ran Pan iD

Psychogeriatrics · 2025

DOI: 10.1111/psyg.70043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychogeriatrics, 2025. Verfasst von Xing Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China. Hauptthemen laut MEDLINE: Alzheimer Disease, MicroRNAs, Microglia, RNA, Long Noncoding. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Research Project of Zhejiang Public Welfare Fund, Jinhua Municipal Science and Technology Plan Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aims to investigate the role of long non‐coding RNA (lncRNA) PRR34 antisense RNA 1 (PRR34‐AS1) and microRNA (miR)‐29c‐3p in Alzheimer's disease (AD) and to explore their mechanisms.

Methods

The study included 35 AD patients and 35 healthy controls. In vitro experiments were conducted using microglial cell lines HMC3 and BV2, which were treated with Aβ25‐35, and gene knockout or overexpression experiments were performed to verify the function of the target genes. PRR34‐AS1 and miR‐29c‐3p levels in serum and cells were detected using RT‐qPCR. Dual luciferase reporter assay and RNA pull‐down assay were conducted to validate the interaction between PRR34‐AS1 and miR‐29c‐3p. The CCK‐8 assay and flow cytometry were used to assess cell viability and apoptosis.

Results

The findings showed that PRR34‐AS1 levels were elevated in the serum of AD patients, while miR‐29c‐3p levels were significantly decreased, with a negative correlation observed between them. Silencing PRR34‐AS1 alleviated the decline in cell viability and increase in apoptosis induced by Aβ25‐35 in microglial cells and inhibited the release of pro‐inflammatory factors. Additionally, a direct interaction between PRR34‐AS1 and miR‐29c‐3p was confirmed. Silencing miR‐29c‐3p counteracted the anti‐inflammatory effects of PRR34‐AS1.

Conclusion

This study discovered that the PRR34‐AS1/miR‐29c‐3p axis played a crucial role in the Aβ25‐35‐induced AD cell model. The inhibition of PRR34‐AS1 can alleviate neuroinflammation and apoptosis in microglial cells, with miR‐29c‐3p serving as a significant mediator in this process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMicroRNAsMicrogliaRNA, Long NoncodingInflammationHumansMaleFemaleApoptosisAgedAmyloid beta-PeptidesGene SilencingCell LinePeptide Fragments

Stichwörter der Autor:innen

ADPRR34‐AS1inflammationmiR‐29c‐3pmicroglia

Substanzen

MicroRNAsRNA, Long NoncodingAmyloid beta-PeptidesMIRN29C microRNA, humanMIRN29a microRNA, humanamyloid beta-protein (25-35)Peptide Fragments

Autor:innen und Institutionen

  • Department of Neurology, The Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.

ORCID-Profile: Xin-Ran Pan

Förderung

  • Research Project of Zhejiang Public Welfare Fund
  • Jinhua Municipal Science and Technology Plan Project

Zitieren

APA

Cheng, X., Chen, H. F., Wang, J. W., & Pan, X. R. (2025). Silencing of lncRNA PRR34 ‐ AS1 Alleviates Alzheimer's Disease by Targeting miR ‐29c‐3p to Regulate Microglia Inflammation. Psychogeriatrics. https://doi.org/10.1111/psyg.70043

Vancouver

Cheng X, Chen HF, Wang JW, Pan XR. Silencing of lncRNA PRR34 ‐ AS1 Alleviates Alzheimer's Disease by Targeting miR ‐29c‐3p to Regulate Microglia Inflammation. Psychogeriatrics. 2025. doi:10.1111/psyg.70043

BibTeX
@article{Cheng2025,
  author = {Cheng, Xing and Chen, Hong-Fang and Wang, Jian-Wei and Pan, Xin-Ran},
  title = {Silencing of lncRNA PRR34 ‐ AS1 Alleviates Alzheimer's Disease by Targeting miR ‐29c‐3p to Regulate Microglia Inflammation},
  journal = {Psychogeriatrics},
  year = {2025},
  doi = {10.1111/psyg.70043}
}
Kostenlos starten →